| pubmed-article:12695313 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12695313 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:12695313 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:12695313 | lifeskim:mentions | umls-concept:C0563664 | lld:lifeskim |
| pubmed-article:12695313 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:12695313 | lifeskim:mentions | umls-concept:C1704532 | lld:lifeskim |
| pubmed-article:12695313 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12695313 | pubmed:dateCreated | 2003-4-15 | lld:pubmed |
| pubmed-article:12695313 | pubmed:abstractText | If there is an increased risk of suicide in the placebo arms of placebo-controlled studies in patients with schizophrenia, it would be a strong ethical argument against the conduct of placebo-controlled studies in this patient population. We tested whether the risk of suicide and attempted suicide in the placebo arms of placebo-controlled studies among patients with schizophrenia is higher than in the active treatment arms of such studies. | lld:pubmed |
| pubmed-article:12695313 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12695313 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12695313 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12695313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12695313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12695313 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12695313 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12695313 | pubmed:issn | 0003-990X | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:KhanArifA | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:WohlfarthTama... | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:StorosumJitsc... | lld:pubmed |
| pubmed-article:12695313 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:12695313 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12695313 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:12695313 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12695313 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12695313 | pubmed:pagination | 365-8 | lld:pubmed |
| pubmed-article:12695313 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:meshHeading | pubmed-meshheading:12695313... | lld:pubmed |
| pubmed-article:12695313 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12695313 | pubmed:articleTitle | Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia. | lld:pubmed |
| pubmed-article:12695313 | pubmed:affiliation | Medicines Evaluation Board of the Netherlands, Den Haag, the Netherlands. JG.Storosum@CBG-MEB.nl | lld:pubmed |
| pubmed-article:12695313 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12695313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12695313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12695313 | lld:pubmed |
